Coverage
-
April 15, 2014
A Delaware federal judge released a written opinion Tuesday explaining that he had on Friday barred most U.S. sales of Medtronic Inc.'s allegedly infringing heart valve systems because rival Edwards Lifesciences AG was likely to win on the merits — a ruling Medtronic has already appealed to the Federal Circuit.
2 other articles on this case.
View all »